Literature DB >> 30291763

Electronic nicotine delivery system (ENDS) use in relation to mental health conditions, past-month serious psychological distress and cigarette smoking status, 2017.

Claire Adams Spears1,2, Dina M Jones1, Scott R Weaver1,3, Bo Yang1, Terry F Pechacek1,4, Michael P Eriksen1,4.   

Abstract

BACKGROUND AND AIMS: Adults with mental health conditions (MHC) exhibit disproportionately high smoking prevalence and experience profound tobacco-related disparities. US nationally representative surveys from 2012 to 2015 found relatively high usage of electronic nicotine delivery systems (ENDS; e.g. e-cigarettes) among adults with MHC. However, research has not examined these associations specifically among never smokers. Aims were to examine associations among MHC diagnosis, serious psychological distress (SPD) and ENDS use and to test whether associations varied by cigarette smoking status.
DESIGN: Cross-sectional US nationally representative survey.
SETTING: United States, 2017. PARTICIPANTS: A total of 5762 adults (52.0% female; 64.8% non-Hispanic white, 11.4% non-Hispanic black, 15.9% Hispanic, 7.9% non-Hispanic other). MEASUREMENTS: Outcomes were lifetime, current and current daily ENDS use. Predictors were lifetime MHC, past-month SPD and cigarette smoking status, and covariates were gender, age, race/ethnicity, education and annual household income.
FINDINGS: lifetime MHC and past-month SPD were each associated with higher likelihood of having ever used ENDS (P ≤ 0.001), currently using ENDS (P ≤ 0.001) and currently using ENDS daily (P < 0.05). There were interactions between MHC and smoking status in predicting ENDS use, such that MHC status predicted higher lifetime and current ENDS use specifically among never and current smokers. Never smokers with MHC had 2.62 higher odds [95% confidence interval, (CI) = 1.54, 4.45] of current ENDS use than those without MHC. Among never smokers, those with MHC indicated higher expectations that ENDS would improve relaxation and concentration (P < 0.05).
CONCLUSIONS: In 2017, US adults with versus without mental health conditions (MHC) were more likely to use electronic nicotine delivery systems (ENDS). In particular, both never and current smokers with MHC reported disproportionately high rates of current ENDS use.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  Cigarettes; e-cigarette outcome expectations; e-cigarettes; electronic nicotine delivery systems; mental health conditions; psychological distress

Year:  2018        PMID: 30291763      PMCID: PMC6314897          DOI: 10.1111/add.14464

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  71 in total

1.  Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.

Authors:  Marie Ng; Michael K Freeman; Thomas D Fleming; Margaret Robinson; Laura Dwyer-Lindgren; Blake Thomson; Alexandra Wollum; Ella Sanman; Sarah Wulf; Alan D Lopez; Christopher J L Murray; Emmanuela Gakidou
Journal:  JAMA       Date:  2014-01-08       Impact factor: 56.272

2.  Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.

Authors:  David B Abrams; Allison M Glasser; Jennifer L Pearson; Andrea C Villanti; Lauren K Collins; Raymond S Niaura
Journal:  Annu Rev Public Health       Date:  2018-01-11       Impact factor: 21.981

3.  Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives.

Authors:  Li-Shiun Chen; Timothy Baker; Ross C Brownson; Robert M Carney; Douglas Jorenby; Sarah Hartz; Nina Smock; Mark Johnson; Douglas Ziedonis; Laura J Bierut
Journal:  Community Ment Health J       Date:  2016-11-30

4.  Smoking and the Reduced Life Expectancy of Individuals With Serious Mental Illness.

Authors:  Jamie Tam; Kenneth E Warner; Rafael Meza
Journal:  Am J Prev Med       Date:  2016-08-10       Impact factor: 5.043

5.  E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications.

Authors:  Stanton A Glantz; David W Bareham
Journal:  Annu Rev Public Health       Date:  2018-01-11       Impact factor: 21.981

Review 6.  Electronic cigarettes for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Hayden McRobbie; Chris Bullen; Rachna Begh; Lindsay F Stead; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2016-09-14

Review 7.  Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit.

Authors:  Peter Hajek; Jean-François Etter; Neal Benowitz; Thomas Eissenberg; Hayden McRobbie
Journal:  Addiction       Date:  2014-07-31       Impact factor: 6.526

8.  Use of e-cigarettes by individuals with mental health conditions.

Authors:  Sharon E Cummins; Shu-Hong Zhu; Gary J Tedeschi; Anthony C Gamst; Mark G Myers
Journal:  Tob Control       Date:  2014-05-12       Impact factor: 7.552

9.  Current Cigarette Smoking Among Adults - United States, 2016.

Authors:  Ahmed Jamal; Elyse Phillips; Andrea S Gentzke; David M Homa; Stephen D Babb; Brian A King; Linda J Neff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-19       Impact factor: 17.586

10.  Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages.

Authors:  Aaron Scott; Sebastian T Lugg; Kerrie Aldridge; Keir E Lewis; Allen Bowden; Rahul Y Mahida; Frances Susanna Grudzinska; Davinder Dosanjh; Dhruv Parekh; Robert Foronjy; Elizabeth Sapey; Babu Naidu; David R Thickett
Journal:  Thorax       Date:  2018-08-13       Impact factor: 9.139

View more
  8 in total

1.  Cigarette Use, E-Cigarette Use, and Dual Product Use Are Higher Among Adults With Serious Psychological Distress in the United States: 2014-2017.

Authors:  Andrea H Weinberger; Jiaqi Zhu; Jessica L Barrington-Trimis; Katarzyna Wyka; Renee D Goodwin
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

2.  Internalizing problems are associated with initiation and past 30-Day use of flavored tobacco products.

Authors:  Ollie Ganz; Amy M Cohn; Renee D Goodwin; Daniel P Giovenco; Olivia A Wackowski; Eugene M Talbot; Cristine D Delnevo
Journal:  Addict Behav       Date:  2021-10-26       Impact factor: 3.913

3.  Discrimination, psychological functioning, and substance use among U.S. young adults aged 18-28, 2017.

Authors:  Dina M Jones; Katherine E Masyn; Claire Adams Spears
Journal:  Exp Clin Psychopharmacol       Date:  2021-08-16       Impact factor: 3.492

4.  Use of and perceptions about electronic nicotine delivery systems (ENDS) among people with mental health conditions or serious psychological distress, 2018.

Authors:  Claire Adams Spears; Dina M Jones; Scott R Weaver; Bo Yang; Terry F Pechacek; Michael P Eriksen
Journal:  Drug Alcohol Depend       Date:  2020-05-13       Impact factor: 4.492

5.  Mental health professionals' perceptions, judgements and decision-making practices regarding the use of electronic cigarettes as a tobacco harm reduction intervention in mental healthcare: A qualitative focus group study.

Authors:  Charlie Albert Smith; Ann McNeill; Loren Kock; Zoyah Ahmed; Lion Shahab
Journal:  Addict Behav Rep       Date:  2019-05-02

Review 6.  A scoping review of studies on the health impact of electronic nicotine delivery systems.

Authors:  Cother Hajat; Emma Stein; Saran Shantikumar; Raymond Niaura; Pietro Ferrara; Riccardo Polosa
Journal:  Intern Emerg Med       Date:  2021-10-12       Impact factor: 3.397

7.  Association of cigarette and electronic nicotine delivery systems use with internalizing and externalizing problems among US adults: Findings from wave 3 (2015-2016) of the PATH study.

Authors:  Bekir Kaplan; Johannes Thrul; Joanna E Cohen
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

8.  Association of psychological distress and current cigarette smoking among Native Hawaiian and Pacific Islander adults and compared to adults from other racial/ethnic groups: Data from the National Health Interview Survey, 2014.

Authors:  Marie-Rachelle Narcisse; Sumit K Shah; Holly C Felix; Page D Dobbs; Pearl A McElfish
Journal:  Prev Med Rep       Date:  2021-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.